An Open-Label Study to Assess the Hepatic Protection Effect of SNP-612, in Patients With NAFLD
Clinical trial NCT03868566 · TERMINATED
Trial details
- NCT number
- NCT03868566
- Sponsor
- Sinew Pharma Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-04
- Primary completion
- 2021-09-22
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.